Public health & evidence
Use population evidence to improve individual and community care.
What to understand
Interpret disease and evidence at population level as well as for the individual patient. Ask who is represented, who benefits and whether the claimed result is clinically meaningful.
- Distinguish prevalence, incidence, cumulative indices and the distribution of need.
- Assess study design, bias, uncertainty and absolute as well as relative effects.
- Choose prevention and improvement measures with meaningful outcome, process and equity checks.
Interpret denominators, distribution and real-world benefit
State the population, time and outcome behind a statistic. Distinguish disease experience, current need and service use. Average improvement may hide concentrated disease or widening inequalities, so assess who is reached and who benefits.
Appraise study design, uncertainty, absolute effects and relevance before applying a finding. Laboratory mechanics, surrogate outcomes and statistical significance answer different questions from clinical benefit. In quality improvement, use process, outcome and balancing measures and observe performance over time, including unintended effects.
- Interpret epidemiological indices and distributions
- Appraise evidence for the question at hand
- Measure improvement and unintended consequences
A core distinction: Evidence appraisal
| Measure | Example: risk falls from 10% to 5% | Interpretation |
|---|---|---|
| Absolute risk reduction | 0.10 − 0.05 = 0.05, or 5 percentage points | Five fewer events per 100 treated over the stated period. |
| Relative risk | 0.05 / 0.10 = 0.5 | Treatment risk is half the comparator risk. |
| Relative risk reduction | 1 − 0.5 = 0.5, or 50% | Must be interpreted with baseline risk. |
| NNT | 1 / 0.05 = 20 | Treat 20 people to prevent one additional event over that period. |
| Number needed to harm | 1 / absolute excess adverse-event risk | A separate outcome that belongs in the benefit–harm discussion. |
| Odds ratio | Odds of an event in one group divided by the other | Not identical to relative risk; approximation is better when events are rare. |
Topics
8 notes
Oral epidemiology
A percentage or average is meaningful only when its population, definition and denominator are clear.
Read detailed note ↗Health inequalities
Disease exposure and the ability to prevent or treat it are shaped by social conditions.
Read detailed note ↗Population prevention
Population prevention changes the conditions that produce exposure, as well as individual choices.
Read detailed note ↗NHS dental systems
Separate the patient’s clinical need from the organisation and funding of the service.
Read detailed note ↗Evidence appraisal
Translate results into absolute patient benefit, then assess whether the study can support the claim. A large relative effect or a small p-value is not sufficient by itself.
Read detailed note ↗Diagnostic tests and statistics
Sensitivity and specificity describe performance within disease groups. Predictive values answer the patient-facing question after a result and depend on the population being tested.
Read detailed note ↗Research ethics
A useful clinical question still needs a defensible design and the correct permissions.
Read detailed note ↗Quality improvement
Test a clear change against meaningful measures and look for unintended effects.
Read detailed note ↗